Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Clinic called it pre curser to pneumonia; got upper respiratory end Dec; Green thick mucus thought it was the end; Green thick mucus thought it was the end.; This serious case was reported by a consumer via interactive digital media and described the occurrence of pneumonia in a elderly patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced pneumonia (Verbatim: Clinic called it pre curser to pneumonia) (serious criteria GSK medically significant), upper respiratory tract infection (Verbatim: got upper respiratory end Dec), mucous membrane disorder (Verbatim: Green thick mucus thought it was the end) and sputum viscosity increased (Verbatim: Green thick mucus thought it was the end.). The outcome of the pneumonia, upper respiratory tract infection, mucous membrane disorder and sputum viscosity increased were not reported. It was unknown if the reporter considered the pneumonia, upper respiratory tract infection, mucous membrane disorder and sputum viscosity increased to be related to RSV vaccine. The company considered the pneumonia to be unrelated to RSV vaccine. It was unknown if the company considered the upper respiratory tract infection, mucous membrane disorder and sputum viscosity increased to be related to RSV vaccine. Additional Information: GSK receipt date 3 Oct 2025 This case was reported by a consumer via interactive digital media. The patient had rsv shot mid-November. The patient got upper respiratory at the end of December. The patient had Green thick mucus thought it was the end and clinic called it as pre curser to pneumonia. The patient recently saw a warning if over 60 should talk to your doctor before getting rsv vaccine if you had certain other conditions.; Sender's Comments: A case of Pneumonia, Unknown time after receiving RSV vaccine, in a elderly patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.